Papers on very long-chain triglycerides
13 papers
Thursday, January 1
Thursday, December 25
Physiology & Behavior
Both a single dose and a 4-week daily regimen of medium-chain triglycerides boost certain aspects of cognitive function in young adults: A randomized controlled trial
Randomized trial in 36 peopleInterventions
Wednesday, May 28
Saturday, August 31
Tuesday, December 19
Frontiers in Nutrition
Medium-chain triglycerides (8:0 and 10:0) increase muscle mass and function in frail older adults: a combined data analysis of clinical trials
Meta-analysis of randomized trialsMuscle
Tuesday, June 20
Neurobiology of Aging
Sex differences in plasma lipid profiles of accelerated brain aging
Cohort study in peoplePopulations
Tuesday, May 9
JCI Insight
Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease
Randomized trial in 25 peopleNicotinamide riboside
Monday, February 6
Journal of Internal Medicine
Metabolomic markers mediate erythrocyte anisocytosis in older adults: Results from three independent aging cohorts
Cohort study of 735 peopleMechanisms
Sunday, February 6
The Journal of Frailty & Aging
Effects of Timing of Medium-Chain Triglycerides (8:0 and 10:0) Supplementation during the Day on Muscle Mass, Function and Cognition in Frail Elderly Adults
Randomized trial in 40 peopleMuscle
Saturday, October 17
Clinical Interventions in Aging
Supplement of Lipid Emulsion to Epinephrine Improves Resuscitation Outcomes of Asphyxia-Induced Cardiac Arrest in Aged Rats
Experiments in animalsInterventions
Sunday, July 12
Thursday, July 25
The American Journal of Clinical Nutrition
Medium-chain triglycerides (8:0 and 10:0) are promising nutrients for sarcopenia: a randomized controlled trial
Trial in peopleInterventions
Tuesday, May 30
Journal of Nutritional Science and Vitaminology
Medium-Chain Triglycerides in Combination with Leucine and Vitamin D Benefit Cognition in Frail Elderly Adults: A Randomized Controlled Trial
Trial in peopleInterventions